Ascendis Pharma A (ASND) Income from Continuing Operations (2014 - 2026)
Ascendis Pharma A (ASND) reported Income from Continuing Operations of $294.33 million for the quarter ended Jun 30, 2026, compared with -$35.27 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Income from Continuing Operations came in at -$641.22 million; for the year ended Dec 31, 2025, it came in at -$195.41 million.
- By year, Income from Continuing Operations came in at -$398.73 million in the year ended Dec 31, 2024, -$504.99 million in the year ended Dec 31, 2023, -$603.33 million in the year ended Dec 31, 2022 and -$438.8 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Income from Continuing Operations in data going back to the quarter ended Mar 31, 2014.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$849.6 million (quarter ended Mar 31, 2026), -$23.1 million (quarter ended Dec 31, 2025) and -$62.84 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 240.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.57 Mn |
| Mar 31, 2026 | -849.60 Mn |
| Dec 31, 2025 | -39.07 Mn |
| Sep 30, 2025 | -71.30 Mn |
| Jun 30, 2025 | -43.98 Mn |
| Mar 31, 2025 | -99.54 Mn |
| Dec 31, 2024 | -41.11 Mn |
| Sep 30, 2024 | -108.94 Mn |
| Jun 30, 2024 | -117.79 Mn |
| Mar 31, 2024 | -142.35 Mn |
| Dec 31, 2023 | -93.48 Mn |
| Sep 30, 2023 | -176.59 Mn |
| Jun 30, 2023 | -132.23 Mn |
| Mar 31, 2023 | -119.05 Mn |
| Dec 31, 2022 | -211.62 Mn |
| Sep 30, 2022 | -170.35 Mn |
| Jun 30, 2022 | -86.77 Mn |
| Mar 31, 2022 | -140.85 Mn |
| Dec 31, 2021 | -121.33 Mn |
| Sep 30, 2021 | -93.56 Mn |
API Access
Ascendis Pharma A Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();